Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shona Hendry

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
The Journal of Molecular Diagnostics : JMD|February 18, 2019
A Novel Approach to Detect Programed Death Ligand 1 (PD-L1) Status and Multiple Tumor Mutations Using a Single Non-Small-Cell Lung Cancer (NSCLC) Bronchoscopy SpecimenAmanda Vannitamby, Shona Hendry, Tanvi Makadia, et al.
Pathology|March 17, 2023
Myeloid sarcoma: a poorly recognised but important differential diagnosis of epithelioid angiosarcomaDaniel D Wong, Rodas Amanuel, Yee Jia Chua, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 28, 2017
Comparison of Four PD-L1 Immunohistochemical Assays in Lung CancerShona Hendry, David J Byrne, Gavin M Wright, et al.
ANZ Journal of Surgery|February 18, 2020
Correlation between percutaneous biopsy and final histopathology for retroperitoneal sarcoma: a single-centre studyRebekah Young, Hayden Snow, Shona Hendry, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2022
Programmed Death-Ligand 1 Copy Number Loss in NSCLC Associates With Reduced Programmed Death-Ligand 1 Tumor Staining and a Cold ImmunophenotypeSavreet Aujla, Christian Aloe, Amanda Vannitamby, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|December 7, 2019
Adequate tumour cellularity is essential for accurate PD-L1 immunohistochemistry assessment on cytology cell-block specimensShona Hendry, David J Byrne, Michael Christie, et al.
Journal of Surgical Oncology|October 21, 2020
Characterising the immune microenvironment in liposarcoma, its impact on prognosis and the impact of radiotherapyHayden Snow, Catherine Mitchell, Shona Hendry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2017
Relationship of the Breast Ductal Carcinoma <i>In Situ</i> Immune Microenvironment with Clinicopathological and Genetic FeaturesShona Hendry, Jia-Min B Pang, David J Byrne, et al.
Cancer Immunology Research|January 31, 2018
Prognostic Significance of PD-L1<sup>+</sup> and CD8<sup>+</sup> Immune Cells in HPV<sup>+</sup> Oropharyngeal Squamous Cell CarcinomaBenjamin Solomon, Richard J Young, Mathias Bressel, et al.
Pathology|October 7, 2023
Adequacy of cytology and small biopsy samples obtained with rapid onsite evaluation (ROSE) for predictive biomarker testing in non-small cell lung cancerShona Hendry, Louis Mamotte, Nima Mesbah Ardakani, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The Journal of Molecular Diagnostics : JMD|February 18, 2019
A Novel Approach to Detect Programed Death Ligand 1 (PD-L1) Status and Multiple Tumor Mutations Using a Single Non-Small-Cell Lung Cancer (NSCLC) Bronchoscopy SpecimenAmanda Vannitamby, Shona Hendry, Tanvi Makadia, et al.
Pathology|March 17, 2023
Myeloid sarcoma: a poorly recognised but important differential diagnosis of epithelioid angiosarcomaDaniel D Wong, Rodas Amanuel, Yee Jia Chua, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 28, 2017
Comparison of Four PD-L1 Immunohistochemical Assays in Lung CancerShona Hendry, David J Byrne, Gavin M Wright, et al.
ANZ Journal of Surgery|February 18, 2020
Correlation between percutaneous biopsy and final histopathology for retroperitoneal sarcoma: a single-centre studyRebekah Young, Hayden Snow, Shona Hendry, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2022
Programmed Death-Ligand 1 Copy Number Loss in NSCLC Associates With Reduced Programmed Death-Ligand 1 Tumor Staining and a Cold ImmunophenotypeSavreet Aujla, Christian Aloe, Amanda Vannitamby, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|December 7, 2019
Adequate tumour cellularity is essential for accurate PD-L1 immunohistochemistry assessment on cytology cell-block specimensShona Hendry, David J Byrne, Michael Christie, et al.
Journal of Surgical Oncology|October 21, 2020
Characterising the immune microenvironment in liposarcoma, its impact on prognosis and the impact of radiotherapyHayden Snow, Catherine Mitchell, Shona Hendry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2017
Relationship of the Breast Ductal Carcinoma <i>In Situ</i> Immune Microenvironment with Clinicopathological and Genetic FeaturesShona Hendry, Jia-Min B Pang, David J Byrne, et al.
Cancer Immunology Research|January 31, 2018
Prognostic Significance of PD-L1<sup>+</sup> and CD8<sup>+</sup> Immune Cells in HPV<sup>+</sup> Oropharyngeal Squamous Cell CarcinomaBenjamin Solomon, Richard J Young, Mathias Bressel, et al.
Pathology|October 7, 2023
Adequacy of cytology and small biopsy samples obtained with rapid onsite evaluation (ROSE) for predictive biomarker testing in non-small cell lung cancerShona Hendry, Louis Mamotte, Nima Mesbah Ardakani, et al.
Pageof 3